 |
PDBsum entry 1r6h
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.3.48
- protein-tyrosine-phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
O-phospho-L-tyrosyl-[protein] + H2O = L-tyrosyl-[protein] + phosphate
|
 |
 |
 |
 |
 |
O-phospho-L-tyrosyl-[protein]
|
+
|
H2O
|
=
|
L-tyrosyl-[protein]
|
+
|
phosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
279:11882-11889
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural insights into molecular function of the metastasis-associated phosphatase PRL-3.
|
|
G.Kozlov,
J.Cheng,
E.Ziomek,
D.Banville,
K.Gehring,
I.Ekiel.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Phosphatases and kinases are the cellular signal transduction enzymes that
control protein phosphorylation. PRL phosphatases constitute a novel class of
small (20 kDa), prenylated phosphatases with oncogenic activity. In particular,
PRL-3 is consistently overexpressed in liver metastasis in colorectal cancer
cells and represents a new therapeutic target. Here, we present the solution
structure of PRL-3, the first structure of a PRL phosphatase. The structure
places PRL phosphatases in the class of dual specificity phosphatases with
closest structural homology to the VHR phosphatase. The structure, coupled with
kinetic studies of site-directed mutants, identifies functionally important
residues and reveals unique features, differentiating PRLs from other
phosphatases. These differences include an unusually hydrophobic active site
without the catalytically important serine/threonine found in most other
phosphatases. The position of the general acid loop indicates the presence of
conformational change upon catalysis. The studies also identify a potential
regulatory role of Cys(49) that forms an intramolecular disulfide bond with the
catalytic Cys(104) even under mildly reducing conditions. Molecular modeling of
the highly homologous PRL-1 and PRL-2 phosphatases revealed unique surface
elements that are potentially important for specificity.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIG. 1. Structure of PRL-3. A, stereo view of the backbone
superposition of the 20 lowest energy structures for residues
Ala^8-Gln156. The unstructured N and C termini are not shown. B,
ribbon representation of the average PRL-3 structure generated
with MOLSCRIPT (41) and Raster3D (42). The secondary structure
elements and N and C termini are labeled.
|
 |
Figure 2.
FIG. 2. PRL phosphatases are highly homologous within their
family but show low sequence similarity to the catalytic domains
of other dual specificity phosphatases. The aligned phosphatases
include human PRL-3 (gi:14589856), PRL-1 (gi:4506283), PRL-2
(gi:4506285), Drosophila PRL-1 (gi:3135665), worm PaRaLysed_cae
(gi:17569857), human VHR (gi:181840), CDC14 (gi:34811075), PTEN
(gi:1916328), and KAP (gi:443669). The secondary structural
elements refer to PRL-3. The catalytic residues are shown in
bold type.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2004,
279,
11882-11889)
copyright 2004.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Q.Al-Aidaroos,
and
Q.Zeng
(2010).
PRL-3 phosphatase and cancer metastasis.
|
| |
J Cell Biochem,
111,
1087-1098.
|
 |
|
|
|
|
 |
R.T.Hao,
X.H.Zhang,
Y.F.Pan,
H.G.Liu,
Y.Q.Xiang,
L.Wan,
and
X.L.Wu
(2010).
Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer.
|
| |
J Cancer Res Clin Oncol,
136,
1349-1357.
|
 |
|
|
|
|
 |
A.L.Skinner,
and
J.S.Laurence
(2009).
1H, 15N, 13C resonance assignments of the reduced and active form of human Protein Tyrosine Phosphatase, PRL-1.
|
| |
Biomol NMR Assign,
3,
61-65.
|
 |
|
|
|
|
 |
E.Mizuuchi,
S.Semba,
Y.Kodama,
and
H.Yokozaki
(2009).
Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression.
|
| |
Int J Cancer,
124,
1802-1810.
|
 |
|
|
|
|
 |
L.Orsatti,
F.Innocenti,
P.Lo Surdo,
F.Talamo,
and
G.Barbato
(2009).
Mass spectrometry study of PRL-3 phosphatase inactivation by disulfide bond formation and cysteine into glycine conversion.
|
| |
Rapid Commun Mass Spectrom,
23,
2733-2740.
|
 |
|
|
|
|
 |
M.Pascaru,
C.Tanase,
A.M.Vacaru,
P.Boeti,
E.Neagu,
I.Popescu,
and
S.E.Szedlacsek
(2009).
Analysis of molecular determinants of PRL-3.
|
| |
J Cell Mol Med,
13,
3141-3150.
|
 |
|
|
|
|
 |
N.Dai,
A.P.Lu,
C.C.Shou,
and
J.Y.Li
(2009).
Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer.
|
| |
World J Gastroenterol,
15,
1499-1505.
|
 |
|
|
|
|
 |
R.Song,
F.Qian,
Y.P.Li,
X.Sheng,
S.X.Cao,
and
Q.Xu
(2009).
Phosphatase of regenerating liver-3 localizes to cyto-membrane and is required for B16F1 melanoma cell metastasis in vitro and in vivo.
|
| |
PLoS ONE,
4,
e4450.
|
 |
|
|
|
|
 |
S.J.Tsai,
U.Sen,
L.Zhao,
W.B.Greenleaf,
J.Dasgupta,
E.Fiorillo,
V.Orrú,
N.Bottini,
and
X.S.Chen
(2009).
Crystal structure of the human lymphoid tyrosine phosphatase catalytic domain: insights into redox regulation .
|
| |
Biochemistry,
48,
4838-4845.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.C.Bessette,
D.Qiu,
and
C.J.Pallen
(2008).
PRL PTPs: mediators and markers of cancer progression.
|
| |
Cancer Metastasis Rev,
27,
231-252.
|
 |
|
|
|
|
 |
R.Pulido,
and
R.Hooft van Huijsduijnen
(2008).
Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease.
|
| |
FEBS J,
275,
848-866.
|
 |
|
|
|
|
 |
U.M.Fagerli,
R.U.Holt,
T.Holien,
T.K.Vaatsveen,
F.Zhan,
K.W.Egeberg,
B.Barlogie,
A.Waage,
H.Aarset,
H.Y.Dai,
J.D.Shaughnessy,
A.Sundan,
and
M.Børset
(2008).
Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells.
|
| |
Blood,
111,
806-815.
|
 |
|
|
|
|
 |
J.Phan,
J.E.Tropea,
and
D.S.Waugh
(2007).
Structure-assisted discovery of Variola major H1 phosphatase inhibitors.
|
| |
Acta Crystallogr D Biol Crystallogr,
63,
698-704.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Yu,
U.Kelly,
J.N.Ebright,
G.Malek,
P.Saloupis,
D.W.Rickman,
B.S.McKay,
V.Y.Arshavsky,
and
C.Bowes Rickman
(2007).
Oxidative stress-induced expression and modulation of Phosphatase of Regenerating Liver-1 (PRL-1) in mammalian retina.
|
| |
Biochim Biophys Acta,
1773,
1473-1482.
|
 |
|
|
|
|
 |
C.A.Byrum,
K.D.Walton,
A.J.Robertson,
S.Carbonneau,
R.T.Thomason,
J.A.Coffman,
and
D.R.McClay
(2006).
Protein tyrosine and serine-threonine phosphatases in the sea urchin, Strongylocentrotus purpuratus: identification and potential functions.
|
| |
Dev Biol,
300,
194-218.
|
 |
|
|
|
|
 |
C.L.Gustafson,
C.V.Stauffacher,
K.Hallenga,
and
R.L.Van Etten
(2005).
Solution structure of the low-molecular-weight protein tyrosine phosphatase from Tritrichomonas foetus reveals a flexible phosphate binding loop.
|
| |
Protein Sci,
14,
2515-2525.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
I.C.Cuevas,
P.Rohloff,
D.O.Sánchez,
and
R.Docampo
(2005).
Characterization of farnesylated protein tyrosine phosphatase TcPRL-1 from Trypanosoma cruzi.
|
| |
Eukaryot Cell,
4,
1550-1561.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |